Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from peripheral academic research consortium (PARC)

Journal of the American College of Cardiology

Volumn 65, Issue 9, 2015, Pages 931-941

  Patel, Manesh R ^a   Conte, Michael S ^b   Cutlip, Donald E ^c,d   Dib, Nabil ^e   Geraghty, Patrick ^f   Gray, William ^g,h   Hiatt, William R ⁱ   Ho, Mami ^j   Ikeda, Koji ^k   Ikeno, Fumiaki ^l   Jaff, Michael R ^m   Jones, W Schuyler ^a   Kawahara, Masayuki ^j   Lookstein, Robert A ⁿ   Mehran, Roxana ^g,n   Misra, Sanjay ^o   Norgren, Lars ^p   Olin, Jeffrey W ⁿ   Povsic, Thomas J ^a   Rosenfield, Kenneth ^m   Rundback, John ^q   Shamoun, Fadi ^r   Tcheng, James ^a   Tsai, Thomas T ^s   Suzuki, Yuka ^j   Vranckx, Pascal ^t   Wiechmann, Bret N ^u   White, Christopher J ^v   Yokoi, Hiroyoshi ^w   Krucoff, Mitchell W ^a   more..

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j PHARMACEUTICALS AND MEDICAL DEVICES AGENCY   (Japan)

^k TOHOKU UNIVERSITY HOSPITAL   (Japan)

^l STANFORD UNIVERSITY   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ MOUNT SINAI MEDICAL CENTER   (United States)

^o MAYO CLINIC   (United States)

^p ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^q Holy Name Medical Center   (United States)

^r MAYO CLINIC   (United States)

^s UNIVERSITY OF COLORADO   (United States)

^t CARDIALYSIS   (Netherlands)

^u Vascular and Interventional Physicians   (United States)

^v OCHSNER MEDICAL CENTER   (United States)

^w KOKURA MEMORIAL HOSPITAL   (Japan)

more..

Author keywords

amputation; foot; intermittent claudication; leg; myocardial infarction; stroke

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DISEASE CLASSIFICATION; FOLLOW UP; HEART HEMODYNAMICS; HUMAN; INTERVENTION STUDY; LEG DISEASE; PATHOLOGICAL ANATOMY; PATIENT SAFETY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; TREATMENT OUTCOME; TREATMENT PLANNING; VASCULAR SURGERY; ANGIOPLASTY; ATHERECTOMY; BLOOD VESSEL PROSTHESIS; CLASSIFICATION; CONSTRICTION, PATHOLOGIC; DIAGNOSTIC IMAGING; ENDARTERECTOMY; LEG; OUTCOME ASSESSMENT; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STENT; VASCULARIZATION; WALKING;

ANGIOPLASTY; ATHERECTOMY; BLOOD VESSEL PROSTHESIS; CONSTRICTION, PATHOLOGIC; DIAGNOSTIC IMAGING; ENDARTERECTOMY; HUMANS; LOWER EXTREMITY; PATIENT OUTCOME ASSESSMENT; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STENTS; WALKING;

EID: 84924690336     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.12.036     Document Type: Review

References (33)

1. T.W. Rooke, A.T. Hirsch, and S. Misra 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2020 2045
2. G.R. Fowkes, D. Rudan, and I. Rudan Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
3. M. Tendera, V. Aboyans, M.L. Bartelink for the European Stroke Organisation ESC Committee on Practice Guidelines ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2851 2906
4. M.R. Jaff, K.E. Cahill, and A.P. Yu Clinical outcomes and medical care costs among Medicare beneficiaries receiving therapy for peripheral arterial disease Ann Vasc Surg 24 2010 577 587
5. S. Subherwal, D.L. Bhatt, and S. Li Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction Circ Cardiovasc Qual Outcomes 5 2012 541 549
6. T.J. Harris, A.M. Zafar, and T.P. Murphy Utilization of lower extremity arterial disease diagnostic and revascularization procedures in Medicare beneficiaries 2000-2007 AJR Am J Roentgenol 197 2011 W314 W317
7. N. Diehm, P.M. Pattynama, and M.R. Jaff Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions Eur J Vasc Endovasc Surg 36 2008 409 419
8. M.S. Conte, P.J. Geraghty, and A.W. Bradbury Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473 e1-3
9. M.A. Creager, M. Belkin, and E.I. Bluth 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease) J Am Coll Cardiol 59 2012 294 357
10. M.W. Krucoff, R. Mehran, and G.A. van Es The academic research consortium governance charter J Am Coll Cardiol Intv 4 2011 595 596
11. D.E. Cutlip, S. Windecker, R. Mehran for the Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
12. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
13. M.B. Leon, N. Piazza, and E. Nikolsky Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
14. A.P. Kappetein, S.J. Head, and P. Genereux for the Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
15. W.R. Hiatt, J. Goldstone, S.C. Smith Jr. for the American Heart Association Writing Group 1 Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases Circulation 118 2008 2826 2829
16. L. Norgren, W.R. Hiatt, J.A. Dormandy for the TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
17. P. Généreux, G.W. Stone, R.A. Harrington for the CHAMPION PHOENIX Investigators Impact of intra-procedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects who Require Percutaneous Coronary Intervention) J Am Coll Cardiol 63 2014 619 629
18. V. Farooq, P.W. Serruys, and Y. Zhang Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX Trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial J Am Coll Cardiol 62 2013 2360 2369
19. P.W. Serruys, V. Farooq, and B. Kalesan Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial J Am Coll Cardiol Intv 6 2013 777 789
20. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 63 2014 299 307
21. A.T. Hirsch, Z.J. Haskal, and N.R. Hertzer ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) J Am Coll Cardiol 47 2006 1239 1312
22. J.A. Dormandy, and R.B. Rutherford Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC) J Vasc Surg 31 1 Pt 2 2000 S1 S296
23. J.J. Castronuovo Jr., H.M. Adera, and J.M. Smiell Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia J Vasc Surg 26 1997 629 637
24. J.L. Mills Sr., M.S. Conte, D.G. Armstrong for the Society for Vascular Surgery Lower Extremity Guidelines Committee The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI) J Vasc Surg 59 2014 220 234 e1-2
25. K.A. Hicks, J.E. Tcheng, and B. Bozkurt 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) J Am Coll Cardiol 2014 Dec 29 http://dx.doi.org/10.1016/j.jacc.2014.12.018
26. K.J. Rocha-Singh, T. Zeller, and M.R. Jaff Peripheral arterial calcification: prevalence, mechanism, detection and clinical implications Catheter Cardiovasc Interv 83 2014 E212 E220
27. H.M. Klomp, E.W. Steyerberg, C.H. Wittens for the ESES Study Group A prognostic model for amputation in critical lower limb ischemia Vasc Med 14 2009 109 115
28. G.I. Taylor, and J.H. Palmer The vascular territories (angiosomes) of the body: experimental study and clinical applications Brit J Plastic Surg 40 1987 113 141
29. V. Aboyans, M.H. Criqui, P. Abraham for the American Heart Association Council on Peripheral Vascular Disease, Council on Epidemiology and Prevention, Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association Circulation 126 2012 2890 2909
30. J. Spertus, P. Jones, and S. Poler The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease Am Heart J 147 2004 301 308
31. K.T. Nead, M. Zhou, and R. Diaz Caceres Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status Circ Cardiovasc Qual Outcomes 6 2013 255 261
32. P.J. Geraghty, J.S. Matsumura, and M.S. Conte Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals J Vasc Surg 50 2009 1459 1461
33. A.W. Bradbury, D.J. Adam, J. Bell for the BASIL Trial Participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification J Vasc Surg 51 2010 32S 42S